Menu
GeneBe

rs281875275

Variant summary

Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM1PM2PP3_ModeratePP5

The NM_000128.4(F11):​c.1693G>A​(p.Glu565Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00000558 in 1,613,106 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 30)
Exomes 𝑓: 0.0000048 ( 0 hom. )

Consequence

F11
NM_000128.4 missense

Scores

3
6
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:2U:1O:1

Conservation

PhyloP100: 3.87
Variant links:
Genes affected
F11 (HGNC:3529): (coagulation factor XI) This gene encodes coagulation factor XI of the blood coagulation cascade. This protein is present in plasma as a zymogen, which is a unique plasma coagulation enzyme because it exists as a homodimer consisting of two identical polypeptide chains linked by disulfide bonds. During activation of the plasma factor XI, an internal peptide bond is cleaved by factor XIIa (or XII) in each of the two chains, resulting in activated factor XIa, a serine protease composed of two heavy and two light chains held together by disulfide bonds. This activated plasma factor XI triggers the middle phase of the intrisic pathway of blood coagulation by activating factor IX. Defects in this factor lead to Rosenthal syndrome, a blood coagulation abnormality. [provided by RefSeq, Jul 2008]
F11-AS1 (HGNC:27725): (F11 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 7 ACMG points.

PM1
In a disulfide_bond (size 67) in uniprot entity FA11_HUMAN there are 14 pathogenic changes around while only 0 benign (100%) in NM_000128.4
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.874
PP5
Variant 4-186287800-G-A is Pathogenic according to our data. Variant chr4-186287800-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 68186.We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=1, Likely_pathogenic=2, not_provided=1}. Variant chr4-186287800-G-A is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
F11NM_000128.4 linkuse as main transcriptc.1693G>A p.Glu565Lys missense_variant 14/15 ENST00000403665.7
F11-AS1NR_033900.1 linkuse as main transcriptn.1066+628C>T intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
F11ENST00000403665.7 linkuse as main transcriptc.1693G>A p.Glu565Lys missense_variant 14/151 NM_000128.4 P1P03951-1
F11-AS1ENST00000505103.5 linkuse as main transcriptn.1005+628C>T intron_variant, non_coding_transcript_variant 1
F11ENST00000264691.4 linkuse as main transcriptc.295G>A p.Glu99Lys missense_variant 2/33
F11ENST00000503841.1 linkuse as main transcriptn.212G>A non_coding_transcript_exon_variant 1/22

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152096
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000479
AC:
7
AN:
1461010
Hom.:
0
Cov.:
31
AF XY:
0.00000275
AC XY:
2
AN XY:
726852
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000270
Gnomad4 OTH exome
AF:
0.0000331
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152096
Hom.:
0
Cov.:
30
AF XY:
0.0000135
AC XY:
1
AN XY:
74290
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000282
Hom.:
0
Bravo
AF:
0.0000151
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:1Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Hereditary factor XI deficiency disease Pathogenic:2
Likely pathogenic, criteria provided, single submitterresearchNIHR Bioresource Rare Diseases, University of CambridgeFeb 01, 2019- -
Likely pathogenic, criteria provided, single submitterliterature onlyCounsylMay 24, 2014- -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpApr 27, 2023Variant summary: F11 c.1693G>A (p.Glu565Lys) results in a conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. 4/4 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. One study reported that this variant causes skipping of exon 14 however the results as presented do not allow a conclusive determination supporting this conclusion (Zucker_20011). The variant was absent in 251488 control chromosomes. c.1693G>A has been reported in the literature as a non-informative genotype (second allele not specified), a homozygous genotype (one report) and as a presumed compound heterozygous genotype (one report) in individuals affected with features of factor XI deficiency disease or in settings of multigene panel testing for coagulation disorders (example, Hill_2005, Qulin_2009, Karimi_2009, Zucker_2011, Rimoldi_2018, Downes_2019). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 31064749, 15953011, 18758779, 20523169, 29178608, 21718436). One group has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. -
not provided Other:1
not provided, no classification providedliterature onlyUniProtKB/Swiss-Prot-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Pathogenic
0.23
D
BayesDel_noAF
Uncertain
0.090
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.58
D;.
Eigen
Benign
-0.034
Eigen_PC
Benign
0.076
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Uncertain
0.89
D;D
M_CAP
Benign
0.066
D
MetaRNN
Pathogenic
0.87
D;D
MetaSVM
Uncertain
0.53
D
MutationAssessor
Benign
1.1
L;.
MutationTaster
Benign
0.63
D;D
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-2.1
N;.
REVEL
Pathogenic
0.65
Sift
Benign
0.15
T;.
Sift4G
Benign
0.096
T;T
Polyphen
0.16
B;.
Vest4
0.55
MutPred
0.83
Gain of MoRF binding (P = 0.0054);.;
MVP
0.98
MPC
0.27
ClinPred
0.82
D
GERP RS
4.8
Varity_R
0.51
gMVP
0.74

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs281875275; hg19: chr4-187208954; API